Literature DB >> 24593214

Successful treatment of rectal ulcers in a patient with systemic lupus erythematosus using corticosteroids and tacrolimus.

Shinjiro Kaieda1, Teppei Kobayashi, Mariko Moroki, Seiyo Honda, Kentaro Yuge, Hiroshi Kawano, Keiichi Mitsuyama, Michio Sata, Hiroaki Ida, Tomoaki Hoshino, Takaaki Fukuda.   

Abstract

Systemic lupus erythematosus (SLE) is frequently accompanied by gastrointestinal symptoms. Although all parts of the gastrointestinal tract may be affected, colonic involvement is quite rare. Colonic ulceration, particularly in the rectum, is associated with a high mortality rate in patients with SLE, despite immunosuppressive therapy. While a standard regimen for treating rectal ulcers as a complication of SLE has not been established, combination therapy with steroids and immunosuppressive agents is necessary because of the associated high mortality rate. In this report, we describe a patient with SLE whose condition was complicated with ulcerative lesions in the rectum and sigmoid colon; the lesions were successfully treated with a combination of corticosteroids and tacrolimus therapy. Tacrolimus could be a useful additional or alternative modality for treating rectal involvement in SLE.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24593214     DOI: 10.3109/14397595.2013.852846

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  3 in total

1.  Rectal ulcers induced by systemic lupus erythematosus.

Authors:  Alan Hoi Lun Yau; Karen Chu; Hui Min Yang; Hin Hin Ko
Journal:  BMJ Case Rep       Date:  2014-08-22

2.  Systemic lupus erythematosus complicated by Crohn's disease with rectovaginal fistula.

Authors:  Heng Yeh; Ren-Chin Wu; Wen-Sy Tsai; Chia-Jung Kuo; Ming-Yao Su; Cheng-Tang Chiu; Puo-Hsien Le
Journal:  BMC Gastroenterol       Date:  2021-05-08       Impact factor: 3.067

3.  Correspondence on '2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus' by Aringer et al.

Authors:  Ran Cui; Qian Wang; Hua Zhang; Shan Wu; Xin-Jian Wan; Sheng-Ming Dai
Journal:  Ann Rheum Dis       Date:  2020-08-04       Impact factor: 27.973

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.